These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27226344)

  • 61. Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.
    Mitrev N; Vande Casteele N; Seow CH; Andrews JM; Connor SJ; Moore GT; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; van Langenberg D; Ward MG; Leong RW;
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1037-1053. PubMed ID: 29027257
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Management of acute severe ulcerative colitis.
    Doherty GA; Cheifetz AS
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):395-405. PubMed ID: 19673626
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
    Lees CW; Heys D; Ho GT; Noble CL; Shand AG; Mowat C; Boulton-Jones R; Williams A; Church N; Satsangi J; Arnott ID;
    Aliment Pharmacol Ther; 2007 Aug; 26(3):411-9. PubMed ID: 17635376
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
    Kopylov U; Papamichael K; Katsanos K; Waterman M; Bar-Gil Shitrit A; Boysen T; Portela F; Peixoto A; Szilagyi A; Silva M; Maconi G; Har-Noy O; Bossuyt P; Mantzaris G; Barreiro de Acosta M; Chaparro M; Christodoulou DK; Eliakim R; Rahier JF; Magro F; Drobne D; Ferrante M; Sonnenberg E; Siegmund B; Muls V; Thurm T; Yanai H; Dotan I; Raine T; Levin A; Israeli E; Ghalim F; Carbonnel F; Vermeire S; Ben-Horin S; Roblin X
    Inflamm Bowel Dis; 2017 Sep; 23(9):1605-1613. PubMed ID: 28590343
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
    Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
    World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
    Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
    Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of severe ulcerative colitis.
    Narula N; Jharap B; Colombel JF
    Curr Treat Options Gastroenterol; 2015 Mar; 13(1):59-76. PubMed ID: 25595929
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis.
    Lee HS; Park SH; Kim SH; Kim J; Choi J; Lee HJ; Kim WS; Lee JM; Kwak MS; Hwang SW; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH; Yang SK
    Inflamm Bowel Dis; 2016 Apr; 22(4):912-8. PubMed ID: 26829410
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acute severe ulcerative colitis trials: the past, the present and the future.
    Honap S; Jairath V; Sands BE; Dulai PS; Danese S; Peyrin-Biroulet L
    Gut; 2024 Sep; 73(10):1763-1773. PubMed ID: 38834296
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
    Monterubbianesi R; Aratari A; Armuzzi A; Daperno M; Biancone L; Cappello M; Annese V; Riegler G; Orlando A; Viscido A; Meucci G; Gasbarrini A; Guidi L; Lavagna A; Sostegni R; Onali S; Papi C; Kohn A;
    J Crohns Colitis; 2014 Aug; 8(8):852-8. PubMed ID: 24472490
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Change in paradigm: impact of an IBD medical home on the outpatient management of acute severe ulcerative colitis.
    Tam V; Schwartz M; Holder-Murray J; Salgado Pogacnik J
    BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31586953
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Delayed Initiation of Rescue Therapy Associated with Increased Length of Stay in Acute Severe Ulcerative Colitis.
    Caplan A; McConnell R; Velayos F; Mahadevan U; Lewin S
    Dig Dis Sci; 2022 Dec; 67(12):5455-5461. PubMed ID: 35389167
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article.
    Rolny P; Vatn M
    Scand J Gastroenterol; 2013 Feb; 48(2):131-5. PubMed ID: 23110487
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Management of the Hospitalized Ulcerative Colitis Patient, the Medical-Surgical Conundrum.
    Carvello M; Watfah J; Spinelli A
    Curr Gastroenterol Rep; 2021 Oct; 23(12):25. PubMed ID: 34716521
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Management of acute severe ulcerative colitis in children.
    Siow VS; Bhatt R; Mollen KP
    Semin Pediatr Surg; 2017 Dec; 26(6):367-372. PubMed ID: 29126505
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.
    Sjöberg M; Walch A; Meshkat M; Gustavsson A; Järnerot G; Vogelsang H; Hertervig E; Novacek G; Friis-Liby I; Blomquist L; Angelberger S; Karlen P; Grännö C; Vilien M; Ström M; Verbaan H; Hellström PM; Dejaco C; Magnuson A; Halfvarson J; Reinisch W; Tysk C
    Inflamm Bowel Dis; 2012 Feb; 18(2):212-8. PubMed ID: 21438096
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Understanding the Perspectives and Experiences of Patients with Acute Severe Ulcerative Colitis in the Hospital: A Qualitative Analysis.
    Romain D; Larson C; Kathuria P; Aintabi D; Tedesco N; Saunyama Q; DeJonckheere M; Bishu S; Cohen-Mekelburg S; Higgins PDR; Berinstein JA
    Dig Dis Sci; 2024 Oct; 69(10):3690-3700. PubMed ID: 39294423
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predicting Outcome after Acute Severe Ulcerative Colitis: A Contemporary Review and Areas for Future Research.
    Vuyyuru SK; Nardone OM; Jairath V
    J Clin Med; 2024 Aug; 13(15):. PubMed ID: 39124775
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Biological agents in ulcerative colitis. When to prescribe].
    Barreiro-de Acosta M
    Gastroenterol Hepatol; 2011 Dec; 34 Suppl 3():36-42. PubMed ID: 25443225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.